Tetsuo Nakano

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

Toshitaka Nakamura, Toshitsugu Sugimoto, Tetsuo Nakano et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 265 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

<i>Clinical Trials Express:</i>Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

Toshitaka Nakamura, Toshio Matsumoto, Toshitsugu Sugimoto et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 168 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

The Risk of a Second Hip Fracture in Patients after Their First Hip Fracture

Hiroshi Hagino, Takeshi Sawaguchi, Naoto Endo et al. · Calcified Tissue International · 2011 · 138 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +9

Effects of unipedal standing balance exercise on the prevention of falls and hip fracture among clinically defined high-risk elderly individuals: a randomized controlled trial

Keizo Sakamoto, Toshitaka Nakamura, Hiroshi Hagino et al. · Journal of Orthopaedic Science · 2006 · 92 citations

Medicine, Orthopedic Surgery, Rehabilitation Medicine +16

Predictors for Ambulatory Ability and the Change in ADL After Hip Fracture in Patients With Different Levels of Mobility Before Injury

Naoshi Fukui, Yoshinobu Watanabe, Tetsuo Nakano et al. · Journal of Orthopaedic Trauma · 2011 · 86 citations

Medicine, Orthopaedic Surgery, Surgery +17